Daily BriefsSingapore

Daily Brief Singapore: Moya Holdings Asia, Singapore Medical and more

In today’s briefing:

  • Moya Holding’s S$0.092 Delisting Offer
  • Moya Holdings: Anthoni Salim’s Exit Offer
  • Singapore Medical’s Light VGO Offer from Top Management
  • Singapore Medical: Management’s Low-Balled Buyout

Moya Holding’s S$0.092 Delisting Offer

By Arun George

  • Moya Holdings Asia (MHAL SP) received a delisting proposal from Tamaris Infrastructure (a 72.84% shareholder) at S$0.092 per share, a 41.5% premium to the undisturbed price (8 September).
  • The key condition is shareholder approval. Gateway Partners, which holds a blocking stake, will likely use the offer as an opportunity to exit an underperforming investment.
  • The offer price is attractive. At the last close price, the gross and annualised spread for a year-end effective date is 3.4% and 11.5%, respectively.

Moya Holdings: Anthoni Salim’s Exit Offer

By David Blennerhassett

  • Indonesian water treatment play Moya Holdings Asia (MHAL SP) has announced an Exit Offer from Tamaris Infrastructure, an Anthoni Salim-controlled entity.
  • The Offer price is S$0.092/share, a 41.5% premium to last close. The Offer price will not be increased.
  • The Offer requires approval from 75% of disinterested shareholders. Tamaris and its concert parties hold 72.84%.

Singapore Medical’s Light VGO Offer from Top Management

By Arun George

  • Singapore Medical (SMG SP) received a voluntary conditional offer from management (chairman, CEO, exec director). The offer is cash (S$0.37) or scrip (1 new share in the offeror per share).
  • The key condition is a 90% minimum acceptance condition. Irrevocables, which will take the scrip option, represent 51.67% of outstanding shares.
  • The offer is light, but the offeror reserves the right to reduce the acceptance condition to a lower level (above 50%). Therefore, this offer will likely turn unconditional. 

Singapore Medical: Management’s Low-Balled Buyout

By David Blennerhassett

  • Healthcare provider Singapore Medical (SMG SP) has announced a voluntary conditional general offer from TLW Success, an entity equally controlled by three senior members of management.
  • TLW is offering A$0.37/share, a 13.8% premium to last close. Shareholders are afforded an unlisted scrip option.
  • TLW shareholders hold 16.49%. Irrevocables another 35.18%, or 51.67% all-in. The Offer is conditional on 90% of shares out held by the Offeror. The acceptance level condition may be reduced. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars